Amgen (Germany) Investor Sentiment

AMG Stock  EUR 253.10  5.35  2.16%   
About 54% of Amgen's shareholders are presently thinking to get in. The analysis of current outlook of investing in Amgen Inc suggests that some traders are interested regarding Amgen's prospects. The current market sentiment, together with Amgen's historical and current headlines, can help investors time the market. In addition, many technical investors use Amgen Inc stock news signals to limit their universe of possible portfolio assets.
Amgen stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Amgen daily returns and investor perception about the current price of Amgen Inc as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Insiders at Amgen Inc. sold US4.9m worth of stock, a potential red flag that needs to be monitored -...
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Inc. is Attracting Investor Attention Here is What You Should Know - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Stock Poised To Break Out - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Amgen jumps after teasing weight-loss drug data, rival stocks fall - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
Amgen in charts Major drug sales grow at slower pace YY, rev from Enbrel dips in Q1 - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWa...
Google News at Macroaxis
over six months ago at news.google.com         
abrdn plc Buys 626,810 Shares of Amgen Inc. - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Suffers a Larger Drop Than the General Market Key Insights - Yahoo Finance UK
Google News at Macroaxis
over six months ago at news.google.com         
Sumitomo Mitsui Trust Holdings Inc. Decreases Stock Holdings in Amgen Inc. - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
7 Analysts Have This To Say About Amgen - Markets Insider
Google News at Macroaxis
over six months ago at news.google.com         
Why Amgen is Poised to Beat Earnings Estimates Again - Yahoo Finance UK
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Receives New Coverage from Analysts at Raymond James - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
AMGEN INC Trade Ideas BCSAMGN TradingView - TradingView
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatc...
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Ascends While Market Falls Some Facts to Note - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Amgen that are available to investors today. That information is available publicly through Amgen media outlets and privately through word of mouth or via Amgen internal channels. However, regardless of the origin, that massive amount of Amgen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amgen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amgen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amgen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amgen alpha.

Amgen Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk